ISSN: 1098-3600
Journal Home
Journal Guideline
Genetics in Medicine Q1 Unclaimed
Genetics in Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Genetics (clinical) with an H index of 159. It has a price of 3000 €. It has an SJR impact factor of 2,697 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,697.
Genetics in Medicine focuses its scope in these topics and keywords: clinical, genetic, variants, colorectal, resource, cancer, medical, consent, xy, data, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
2,697
SJR Impact factor159
H Index184
Total Docs (Last Year)864
Total Docs (3 years)7073
Total Refs4645
Total Cites (3 years)742
Citable Docs (3 years)5.18
Cites/Doc (2 years)38.44
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Introduction
View moreMeetings Calendar
View moreDoes knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing?
View moreAttitudes of African American premedical students toward genetic testing and screening
View moreClinical validation of genetic tests
View moreFostering applications of genetics in primary care: What will it take?
View moreIn Response
View moreBiochemical genetics: From mechanisms to diagnosis and management of genetic disease
View moreStructural brain abnormalities in adult males with clefts of the lip and/or palate
View moreReflections on the ethics of genetic enhancement
View moreHeterogeneity of late-infantile neuronal ceroid lipofuscinosis
View moreClinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C
View moreInsurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations
View moreHereditary hemochromatosis: Perspectives of public health, medical genetics, and primary care
View moreExtensive sequencing of the cystic fibrosis transmembrane regulator gene: Assay validation and unexpected benefits of developing a comprehensive test
View moreDetection of deletions in de novo "balanced" chromosome rearrangements: Further evidence for their role in phenotypic abnormalities
View moreAttitudes of the broader hearing, deaf, and hard-of-hearing community toward genetic testing for deafness
View moreThe GM2 gangliosidoses datanases: Allelic variation at the HEXA, HEXB, and GMWA gene loci
View moreWhy has the relationship between psychiatry and genetics been so contentious?
View moreAdvocating for genetics at the local level: The Medicare Part B Carrier Advisory Committee
View moreAllele frequency determination of publicly available cSNPs in the Korean population
View moreMolecular diagnosis and inborn errors of metabolism: A practitioner's view
View moreSome ethical implications of The Human Genome Project
View moreMapping the human genome: An assessment of media coverage and public reaction
View more
Comments